A Glimpse Into The Expert Outlook On Moderna Through 5 Analysts
A Glimpse Into The Expert Outlook On Moderna Through 5 Analysts
通過5位分析師一窺Moderna的專家展望
In the last three months, 5 analysts have published ratings on Moderna (NASDAQ:MRNA), offering a diverse range of perspectives from bullish to bearish.
在過去的三個月中，有5位分析師公佈了對Moderna（納斯達克股票代碼：MRNA）的評級，提供了從看漲到看跌的不同視角。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表簡要概述了分析師最近的評級，提供了對過去30天情緒變化的見解，並與前幾個月進行了比較以獲得整體視角。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $113.8, a high estimate of $142.00, and a low estimate of $86.00. Observing a 44.97% increase, the current average has risen from the previous average price target of $78.50.
分析師通過對12個月目標股價的評估提供了更深入的見解，顯示平均目標價爲113.8美元，最高估計爲142.00美元，低估值爲86.00美元。目前的平均價格上漲了44.97％，已從之前的平均目標股價78.50美元上漲。
Understanding Analyst Ratings: A...
了解分析...
登入免費觀看全文
登入/註冊